Mutations in the growth regulatory genes BRAF and KRAS appear to be associated with the development of low-grade ovarian cancer but not of aggressive high-grade ovarian cancer, according to a study in ...
CHICAGO -- Dual targeted therapy with a BRAF and MEK inhibitor quadrupled responses in pediatric BRAF-mutant low-grade glioma and reduced risk of disease progression or death compared with standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results